FDA Adverse Event Injury Summary report: N

KUGEL PATCH

MDR report key: 1973874 · Received January 19, 2011

Report

Report Number
1213643-2011-00021
Event Type
Injury
Date Received
January 19, 2011
Date of Event
February 4, 2010
Report Date
December 30, 2010
Manufacturer
DAVOL INC., SUB. C.R. BARD, INC.
Product Code
FTL
PMA / PMN Number
K963141
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
RI, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

WE HAVE CONTACTED THE INITIAL RPTR TO REQUEST ADDITIONAL INFO AND TO REQUEST RETURN OF THE DEVICE FOR EVAL. THIS MDR INCLUDES ALL PT, EVENT AND DEVICE INFO DAVOL HAS RECEIVED TO DATE. CURRENTLY, IT IS UNK WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME.

Description of Event or Problem · 1

ATTORNEY REPORTED: ON (B)(6) 1999: TWO KUGEL HERNIA MESH PATCHES WERE USED TO REPAIR PT'S HERNIA DEFECT. ON (B)(6) 2010: PT PRESENTED TO THE HOSPITAL WITH INTENSE ABDOMINAL PAIN. HIS SURGEON DECIDED TO TAKE HIM INTO SURGERY ON THE SAME DAY WHERE HE FOUND A 2-3 MM DIAMETER FIBRIL OF PLASTIC MEASURING APPROXIMATELY 3 INCHES IN LENGTH THAT WAS REMOVED. HE ALSO NOTED THAT THE MESH HAD ALSO MOST LIKELY MIGRATED AND ERODED THROUGH THE INGUINAL WALL AND HAD ADHERED TO THE SIGMOID COLON CAUSING A PERFORATION. THE COLON AND PORTIONS OF THE BOWEL HAD TO BE RESECTED. ON (B)(6) 2010: PT PRESENTED TO THE ER WITH CONTINUED PAIN. IT WAS DETERMINED THAT PT HAD DEVELOPED AN ABSCESS AND INFECTION, WHICH REQUIRED ADDITIONAL SURGERY TO REPAIR. ON (B)(6) 2010: PT WAS REVIEWED AT THE HOSPITAL AND DETERMINED TO HAVE A FISTULA ADJACENT TO THE SMALL BOWEL. THIS REQUIRED ANOTHER ADDITIONAL SURGERY. PT HAS SUFFERED AND WILL CONTINUE TO SUFFER PHYSICAL PAIN AND MENTAL ANGUISH.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 KUGEL PATCH FTL DAVOL INC., SUB. C.R. BARD, INC. NA 121198

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention